Ferrous Sulphate

Ferrous Sulphate used to prevent or treat low iron blood levels in iron deficiency anemia.


Adult Dose
Dose: 150 to 300 mg
Single Dose: 220 (225)
Frequency: 12 hourly
Route: PO
Instructions:
Neonatal
Dose: 7.5 mg/kg
Single Dose: 7.5 (7.5)
Frequency: 8 hourly
Route: Oral
Instructions:
Paedriatic
Dose: 12 mg/kg
Single Dose: 12 (12)
Frequency: 8 hourly
Route: Oral
Instructions: -
Characteristics
Ferrous Sulphate also known as Green Vitriol, Green Vitriol, Green Vitriol. . It is of Synthetic origin. It belongs to Hematological Agents and Iron Salt pharmacological group.The Molecular Weight of Ferrous Sulphate is 278.00. It is strongly acidic drug.
Contraindications
Ferrous Sulphate is contraindicated in conditions like Hemochromatosis,Haemolytic anaemia,Haemosiderosis.
Effects
The symptomatic adverse reactions produced by Ferrous Sulphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Diarrhea, Constipation, Epigastric discomfort, Black stool, Staining of teeth.
Indications
Ferrous Sulphate is primarily indicated in conditions like Acute diarrhoea, Anaemia, Iron deficiency anaemia, Iron-deficiency anaemia prophylaxis or for mild iron deficiency, Iron-deficiency anaemia with chronic renal failure, Mild iron-deficiency anaemias, and can also be given in adjunctive therapy as an alternative drug of choice in Chronic inflammatory disease.
Interactions
Ferrous Sulphate is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementSulphasalazine These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Tab, Syrup Store in a well closed container, Below 40°C. Protect from Sunlight.
Warnings
Discontinue use if symptoms of intolerance appear. Occasional gastrointestinal (GI) discomfort, as nausea, may be minimized by taking it with meal. Care should be taken in the patient who may develop iron overload, such as those with the haemochromatosis, hemolytic anemia or red cell aplasia. Iron chelates with tetracylines and the absorption of both products may be impaired. The absorption of drug may be impaired by the penicillamine and by antacid. Such interaction can be reduced by separating administration of each products by several hours.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.